KOSDAQ · Healthcare · ₩285B
₩8,630-3.58%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 5.4% · as of 26.10.27
Among 98 제약 peers
Quarterly Revenue Growth
“진단 제품 확대와 치료제 개발로 사업이 다음 단계에 들어섰어요.”
In the company's words · 2026 2분기 filing